According to Sequent Scientific's latest financial reports the company has $7.44 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $5.07 M | -34.97% |
2022-03-31 | $7.79 M | -4.09% |
2021-03-31 | $8.12 M | -43.39% |
2020-03-31 | $14.36 M | 46.15% |
2019-03-31 | $9.82 M | 12.45% |
2018-03-31 | $8.73 M | -49.23% |
2017-03-31 | $17.21 M | 31.3% |
2016-03-31 | $13.1 M | 263.8% |
2015-03-31 | $3.6 M | -6.39% |
2014-03-31 | $3.84 M | 475.93% |
2013-03-31 | $0.66 M | -87.68% |
2012-03-31 | $5.42 M | 154.87% |
2011-03-31 | $2.12 M | -32.2% |
2010-03-31 | $3.14 M | 288.67% |
2009-03-31 | $0.8 M | -21.98% |
2008-03-31 | $1.03 M | -28.63% |
2007-03-31 | $1.45 M |